Skip to main content

Juvenile dermatomyositis

Publication ,  Journal Article
Reed, AM; Pilkington, CA; Feldman, BM; Pachman, LM; Rider, LG
December 1, 2009

Children with inflammatory myopathies have clinical and laboratory features, as well as risk factors and outcomes that overlap with their adult counterparts. However, a number of important differences exist between pediatric and adult disease. Juvenile dermatomyositis (JDM), the most common of this group of illnesses in children, has an incidence of approximately 3.2 cases/million children/year. JDM has a gender ratio of 2 girls:1 boy. JDM has a mean age of 6.7 years at disease onset. The duration of active disease before the time of diagnosis alters the patients' features at presentation as well as their clinical outcomes. Environmental and genetic factors affect the child's susceptibility to these conditions and also alter the inflammatory response, adding heterogeneity to disease pathophysiology. © 2010 Springer-Verlag London.

Duke Scholars

DOI

Publication Date

December 1, 2009

Start / End Page

201 / 209
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reed, A. M., Pilkington, C. A., Feldman, B. M., Pachman, L. M., & Rider, L. G. (2009). Juvenile dermatomyositis, 201–209. https://doi.org/10.1007/978-1-84800-934-9_19
Reed, A. M., C. A. Pilkington, B. M. Feldman, L. M. Pachman, and L. G. Rider. “Juvenile dermatomyositis,” December 1, 2009, 201–9. https://doi.org/10.1007/978-1-84800-934-9_19.
Reed AM, Pilkington CA, Feldman BM, Pachman LM, Rider LG. Juvenile dermatomyositis. 2009 Dec 1;201–9.
Reed, A. M., et al. Juvenile dermatomyositis. Dec. 2009, pp. 201–09. Scopus, doi:10.1007/978-1-84800-934-9_19.
Reed AM, Pilkington CA, Feldman BM, Pachman LM, Rider LG. Juvenile dermatomyositis. 2009 Dec 1;201–209.

DOI

Publication Date

December 1, 2009

Start / End Page

201 / 209